Synthetic cannabinoids have caused a large number of emergency presentations to hospitals for adverse cardiovascular events including numerous deaths, particularly for the more potent analogs acting on the CB<sub>1</sub> receptor. While smoked cannabis use is often associated with significant change … An AP investigation shows that a troubling number of CBD products are spiked with synthetic marijuana, which can cause comas, psychotic behavior, and death.
Cannabis as a cause of death: A review
Synthetic cannabinoids have caused a large number of emergency presentations to hospitals for adverse cardiovascular events including numerous deaths, particularly for the more potent analogs acting on the CB1 receptor. While smoked cannabis use is often associated with significant changes in heart rate and cardiac output, amongst other physiological changes, it has been rarely considered in the forensic literature as a significant contributory or causal factor in sudden unexpected death. A review of case reports of admissions to hospitals for cardiovascular events was undertaken together with a review of epidemiological studies, and case reports of sudden death attributed, at least in part, to use of this drug. These publications show that use of cannabis is not without its risks of occasional serious medical emergencies and sudden death, with reports of at least 35 persons presenting with significant cardiovascular emergencies who had recently smoked a cannabis preparation. At least 13 deaths from a cardiovascular mechanism have been reported from use of this drug which is very likely to be an under-estimate of the true incidence of its contribution to sudden death. In addition, many cases of stroke and vascular arteritis have also been reported with the latter often involving a limb amputation. While it is a drug with widespread usage among the community with relatively few deaths when faced with a circumstance of very recent use (within a few hours), a positive blood concentration of THC and a possible cardiac-related or cerebrovascular cause of death this drug should be considered, at least, a contributory cause of death in cases of sudden or unexpected death.
Keywords: Arrhythmias; Cardiovascular disease; Forensic; Heart disease; Myocardial infarction; Stroke.
Copyright © 2019 Elsevier B.V. All rights reserved.
Thomas G, Kloner RA, Rezkalla S. Thomas G, et al. Am J Cardiol. 2014 Jan 1;113(1):187-90. doi: 10.1016/j.amjcard.2013.09.042. Epub 2013 Oct 5. Am J Cardiol. 2014. PMID: 24176069 Review.
Richards JR, Bing ML, Moulin AK, Elder JW, Rominski RT, Summers PJ, Laurin EG. Richards JR, et al. Clin Toxicol (Phila). 2019 Oct;57(10):831-841. doi: 10.1080/15563650.2019.1601735. Epub 2019 Apr 9. Clin Toxicol (Phila). 2019. PMID: 30964363
Hartung B, Kauferstein S, Ritz-Timme S, Daldrup T. Hartung B, et al. Forensic Sci Int. 2014 Apr;237:e11-3. doi: 10.1016/j.forsciint.2014.02.001. Epub 2014 Feb 12. Forensic Sci Int. 2014. PMID: 24598271
Moustafa B, Testai FD. Moustafa B, et al. Curr Neurol Neurosci Rep. 2021 Apr 7;21(6):25. doi: 10.1007/s11910-021-01113-2. Curr Neurol Neurosci Rep. 2021. PMID: 33825077 Review.
Hackam DG. Hackam DG. Stroke. 2015 Mar;46(3):852-6. doi: 10.1161/STROKEAHA.115.008680. Stroke. 2015. PMID: 25700287 Review.
Bockmann EC, Brito R, Madeira LF, da Silva Sampaio L, de Melo Reis RA, França GR, Calaza KDC. Bockmann EC, et al. Cell Mol Neurobiol. 2022 Aug 4. doi: 10.1007/s10571-022-01263-y. Online ahead of print. Cell Mol Neurobiol. 2022. PMID: 35925507 Review.
Edinoff AN, Doppalapudi P, Fort JM. Edinoff AN, et al. Health Psychol Res. 2022 Apr 26;10(3):34617. doi: 10.52965/001c.34617. eCollection 2022. Health Psychol Res. 2022. PMID: 35774900 Free PMC article.
Weresa J, Pędzińska-Betiuk A, Mińczuk K, Malinowska B, Schlicker E. Weresa J, et al. Cells. 2022 Mar 28;11(7):1142. doi: 10.3390/cells11071142. Cells. 2022. PMID: 35406706 Free PMC article. Review.
Gahr M, Ziller J, Keller F, Muche R, Preuss UW, Schönfeldt-Lecuona C. Gahr M, et al. Eur J Public Health. 2022 Apr 1;32(2):239-245. doi: 10.1093/eurpub/ckab207. Eur J Public Health. 2022. PMID: 35043164 Free PMC article.
Murata T, Noritake K, Aki T, Uemura K. Murata T, et al. Toxicol Rep. 2021 Apr 30;8:980-987. doi: 10.1016/j.toxrep.2021.04.014. eCollection 2021. Toxicol Rep. 2021. PMID: 34026562 Free PMC article.
Some CBD Tainted With Substance That Causes Death, Comas, Insanity
Thanks to patchwork regulation, a number of CBD products contain stuff that could cause a psychotic episode — or even kill you.
A troubling trend: vapes and other products advertised as containing CBD are actually spiked with synthetic marijuana, a dangerous drug that’s been linked with deaths, serious hospitalizations, and psychosis.
Poring over a collection of police records and the findings of its own investigation into CBD products, The Associated Press found that many products labeled as CBD products only contain trace amounts of the chemical, which advocates claim treats a range of medical maladies.
But many contained dangerous synthetic marijuana — and tracking down the perpetrators meant leaping down a rabbit hole of weak government regulations and shady business practices.
In a separate report, the AP found that 128 of the 350 CBD products tested by American law enforcement agencies contained synthetic marijuana, as did ten of the 30 tested by the AP.
“It’s Russian roulette,” James Neal-Kababick told the AP. He’s the director of Flora Research Laboratories, which the AP commissioned to run the tests CBD products. Synthetic marijuana poses an ongoing problem that’s unrelated to recent cases of a mysterious “vape lung” illness.
The AP also profiled cases like one in which a college student fell into a coma after two hits of a spiked CBD vape. In Utah, that same brand hospitalized 33 people. In another case, an eight-year-old boy was hospitalized when his parents tried to treat his seizures with spiked CBD oil. In Europe, the synthetic marijuana that popped up in the AP‘s investigation has killed 11. In those and other cases investigated by the AP, the products’ packaging made no mention of synthetic marijuana.
The FDA is in charge of regulating CBD because it’s approved at least one pharmaceutical that uses the drug as an active ingredient. A spokesperson told the AP that if synthetic marijuana is found in a product, it becomes the DEA’s problem. But a DEA spokesperson told the AP that synthetic marijuana is a low priority for the agency.
“As long as it remains unregulated like it currently is,” Virginia Commonwealth University researcher Michelle Peace told the AP, “you just give a really wide space for nefarious activity to continue.”